Trial Profile
Observational, cohort study assessing the risk of breast cancer in Risperidone users.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2016
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Aggression; Autistic disorder; Bipolar disorders; Schizophrenia
- Focus Adverse reactions
- 05 Nov 2016 New trial record